MedPath
NMPA Approval

Ranitidine Hydrochloride Tablets

国药准字H41023402

April 7, 2024

Drug Information

盐酸雷尼替丁片

片剂

按C13H22N4O3S计 150mg

化学药品

April 7, 2024

Company Information

Applicant Company

驻马店市驿城区光明路2号

Manufacturing Company

驻马店市驿城区光明路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁片 - NMPA 批准文号 | MedPath